What to look forward to in GaBI Journal, 2015, Issue 2

Author(s): Professor Philip D Walson, MD

This entire issue of the GaBI Journal could be titled ‘World News’ since it contains manuscripts describing global generics and biosimilar activities. The Commentary by Leng et al. describes regulatory events in South Africa that led to claims of delay in marketing approval of generic drug products. The authors discuss the relationship between regulatory policies […]

Read more →